Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
About this item
Full title
Author / Creator
Kelly, Richard J , Höchsmann, Britta , Szer, Jeff , Kulasekararaj, Austin , de Guibert, Sophie , Röth, Alexander , Weitz, Ilene C , Armstrong, Elina , Risitano, Antonio M , Patriquin, Christopher J , Terriou, Louis , Muus, Petra , Hill, Anita , Turner, Michelle P , Schrezenmeier, Hubert and Peffault de Latour, Regis
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Pregnancy has been discouraged in patients with paroxysmal nocturnal hemoglobinuria, a life-threatening hemolytic anemia, because of the heightened risk. However, in this study, eculizumab protected the mother and had no obvious adverse effect on the babies.
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired stem-cell disorder that is...
Alternative Titles
Full title
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1711543947
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1711543947
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1502950
